These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 29603832)

  • 21. Change in hepatitis A epidemiology after vaccinating high risk children in Taiwan, 1995-2008.
    Tsou TP; Liu CC; Huang JJ; Tsai KJ; Chang HF
    Vaccine; 2011 Apr; 29(16):2956-61. PubMed ID: 21329774
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Time trends in pediatric hospitalizations for hepatitis A in Greece (1999-2013): Assessment of the impact of universal infant immunization in 2008.
    Papaevangelou V; Alexopoulou Z; Hadjichristodoulou C; Kourlamba G; Katsioulis A; Theodoridou K; Spoulou V; Theodoridou M
    Hum Vaccin Immunother; 2016 Jul; 12(7):1852-6. PubMed ID: 27141813
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Incidence of hepatitis A in Israel following universal immunization of toddlers.
    Dagan R; Leventhal A; Anis E; Slater P; Ashur Y; Shouval D
    JAMA; 2005 Jul; 294(2):202-10. PubMed ID: 16014594
    [TBL] [Abstract][Full Text] [Related]  

  • 24. From hepatitis B to hepatitis A and B prevention: the Puglia (Italy) experience.
    Germinario C; Lopalco PL; Chirona M; Da Villa G
    Vaccine; 2000 Feb; 18 Suppl 1():S83-5. PubMed ID: 10683558
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Impact of hepatitis A vaccination on health care utilization in the United States, 1996-2004.
    Zhou F; Shefer A; Weinbaum C; McCauley M; Kong Y
    Vaccine; 2007 May; 25(18):3581-7. PubMed ID: 17306908
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The impact of immigration and vaccination in reducing the incidence of hepatitis B in Catalonia (Spain).
    Oviedo M; Muñoz MP; Carmona G; Borrás E; Batalla J; Soldevila N; Domínguez A
    BMC Public Health; 2012 Aug; 12(1):614. PubMed ID: 22867276
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Impact of the national targeted Hepatitis A immunisation program in Australia: 2000-2014.
    Thompson C; Dey A; Fearnley E; Polkinghorne B; Beard F
    Vaccine; 2017 Jan; 35(1):170-176. PubMed ID: 27876203
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Acute hepatitis B 14 years after the implementation of universal vaccination in Italy: areas of improvement and emerging challenges.
    Mele A; Tosti ME; Mariano A; Pizzuti R; Ferro A; Borrini B; Zotti C; Lopalco P; Curtale F; Balocchini E; Spada E;
    Clin Infect Dis; 2008 Mar; 46(6):868-75. PubMed ID: 18269332
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Regional variation in the cost effectiveness of childhood hepatitis A immunization.
    Jacobs RJ; Greenberg DP; Koff RS; Saab S; Meyerhoff AS
    Pediatr Infect Dis J; 2003 Oct; 22(10):904-14. PubMed ID: 14551492
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The United States and Canada as a coupled epidemiological system: an example from hepatitis A.
    Amariei R; Willms AR; Bauch CT
    BMC Infect Dis; 2008 Feb; 8():23. PubMed ID: 18307785
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Incidence of Hepatitis A in Argentina after vaccination.
    Vacchino MN
    J Viral Hepat; 2008 Oct; 15 Suppl 2():47-50. PubMed ID: 18837834
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Impact of the single-dose universal mass vaccination strategy against hepatitis A in Brazil.
    Souto FJD; de Brito WI; Fontes CJF
    Vaccine; 2019 Feb; 37(6):771-775. PubMed ID: 30639462
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of hepatitis A vaccination programs for migrant children on the incidence of hepatitis A in The Netherlands.
    Suijkerbuijk AW; Lindeboom R; van Steenbergen JE; Sonder GJ; Doorduyn Y
    Eur J Public Health; 2009 Jun; 19(3):240-4. PubMed ID: 19174503
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Declining hepatitis A seroprevalence in adults in Catalonia (Spain): a population-based study.
    Domínguez A; Bruguera M; Plans P; Espuñes J; Costa J; Plasencia A; Salleras L
    BMC Infect Dis; 2007 Jul; 7():73. PubMed ID: 17610736
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [The coverage of hepatitis A vaccine among 2-29 year olds and the reporting incidence of hepatitis A in China, 2014].
    Wang FZ; Zheng H; Liu JH; Sun XJ; Miao N; Shen LP; Zhang GM; Cui FQ
    Zhonghua Liu Xing Bing Xue Za Zhi; 2016 Aug; 37(8):1099-104. PubMed ID: 27539340
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Incidence of hepatitis A in the United States in the era of vaccination.
    Wasley A; Samandari T; Bell BP
    JAMA; 2005 Jul; 294(2):194-201. PubMed ID: 16014593
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Seroepidemiology of hepatitis A and hepatitis B virus in Luxembourg.
    Mossong J; Putz L; Patiny S; Schneider F
    Epidemiol Infect; 2006 Aug; 134(4):808-13. PubMed ID: 16436219
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Progress Toward Eliminating Hepatitis A Disease in the United States.
    Murphy TV; Denniston MM; Hill HA; McDonald M; Klevens MR; Elam-Evans LD; Nelson NP; Iskander J; Ward JD
    MMWR Suppl; 2016 Feb; 65(1):29-41. PubMed ID: 26916458
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The underestimated risk of hepatitis A and hepatitis B: benefits of an accelerated vaccination schedule.
    Keystone JS; Hershey JH
    Int J Infect Dis; 2008 Jan; 12(1):3-11. PubMed ID: 17643334
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The A's and B's of vaccine-preventable hepatitis: improving prevention in high-risk adults.
    Oldfield EC; Keeffe EB
    Rev Gastroenterol Disord; 2007; 7(1):1-21. PubMed ID: 17392626
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.